Abstract
Epidermodysplasia verruciformis (EV) is a rarely seen, genetically transmitted dermatosis characterized by the tendency to human papillomavirus infections (HPV). Although its etiopathogenesis is not exactly known, dysfunction in cell-mediated immunity is thought to be a very important factor in the development of the disease. Verruca plana, which starts in childhood, and reddish-brown papules and plaques mimicking pityriasis versicolor are seen in EV cases. There are no specific races or geographical differences in the incidence of the disease. On histopathological examination, hiperkeratosis, acanthosis, and intense vacuolization similar to those in classic verruca vulgaris can be seen. Especially in the sun-exposed areas, malignancies may develop. Therefore, early diagnosis and treatment of the disease is significant for the prevention of premalignant and malignant lesions. Some medications such as interferon, retinoic acid, topical imiquimod can be used in the treatment. Here, we present a 14-year-old epidermodysplasia verruciformis case having partially positive response to acitretin treatment Key Words: Epidermodysplasia Verruciformis (EV); Human Papillomavirus (HPV); Acitretin
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
